"Designing Growth Strategies is in our DNA"

Central Lab Services Market Size, Share & Industry Analysis By Service Type (Safety Testing, Biomarker Testing, Genetic Testing, Immunology Testing, Anatomic Pathology & Histology, Microbiology & Infectious Disease Testing, Bioanalytical Testing, & Others), By Phase (Phase I, Phase II, Phase III, & Phase IV), By Modality (Small Molecules, Biologics, Medical Devices, & Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Cardiology, & Others), By End User (Pharmaceutical & Biotechnological Companies, Medical Device Companies, CROs, & Others), and Regional Forecast, 2026-2034

Last Updated: June 24, 2026 | Format: PDF | Report ID: FBI107163

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 261
Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann